Filing Details
- Accession Number:
- 0001209191-22-060587
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 19:38:31
- Reporting Period:
- 2022-12-06
- Accepted Time:
- 2022-12-09 19:38:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1820187 | D Marlan Walker | 951 Yamato Road Suite 220 Boca Raton FL 33431 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-06 | 1,010 | $0.00 | 6,189 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-06 | 1,156 | $0.00 | 7,345 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-06 | 388 | $0.00 | 7,733 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-06 | 1,048 | $4.95 | 6,685 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2022-12-06 | 1,010 | $0.00 | 1,010 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2022-12-06 | 1,156 | $0.00 | 1,156 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2022-12-06 | 388 | $0.00 | 388 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,010 | No | 4 | M | Direct | ||
| 2,311 | No | 4 | M | Direct | ||
| 770 | No | 4 | M | Direct |
Footnotes
- Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).
- The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $4.66 through $5.41, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- The RSUs vest in three equal installments annually, becoming fully vested on March 30, 2023.
- The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.
- Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.
Billionaire Hedge Funds
